Dabigatran Etexilate : Pharmacology of the New, Oral Direct Thrombin Inhibitor
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-08-01
著者
-
Clemens Andreas
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim, Germany
-
Hauel Norbert
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim, Germany
-
Wienen Wolfgang
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim, Germany
-
HAUEL Norbert
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim
-
VAN RYN
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim
関連論文
- Dabigatran Etexilate : Pharmacology of the New, Oral Direct Thrombin Inhibitor
- Dabigatran Etexilate : Pharmacology of the New, Oral Direct Thrombin Inhibitor